Viscoryl 1 mg/5 ml is a syrup product of Albion Laboratories Ltd. that contains Levosalbutamol. Viscoryl 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease.
There are 41 brands of Levosalbutamol listed in Bangladesh. 25 of them have a lower unit price than Viscoryl. The lowest listed price is Purilin 1 mg Tablet at ৳ 0.9 per unit.
What is Viscoryl 1 mg/5 ml Syrup?
Viscoryl 1 mg/5 ml is a syrup product of Albion Laboratories Ltd. that contains Levosalbutamol. The active substance relaxes the smooth muscle of the airways, which helps when breathing is narrowed by reversible obstructive airway disease. How much to take and for how long is decided by the doctor, since the dose and course depend on the person. The doctor will decide the dose and course for each person.
Uses of Viscoryl
Viscoryl 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease. Bronchospasm is a narrowing of the airways that makes breathing difficult. It is not for every kind of breathing problem, so your doctor will confirm whether it is appropriate for your condition and whether any other medicines are needed alongside it. Your doctor will decide how and when you should use it, based on your condition.
How to use Viscoryl
The exact number of inhalations, how often to use it and for how long are decided by your doctor. Measure the liquid with the cap or spoon that comes with the pack. Viscoryl is taken by mouth. Take Viscoryl syrup exactly as your doctor tells you. Do not change the dose or stop using it without asking your doctor. The doctor decides the dose, how often it is given and how long the course lasts, including for children and for adults.
Side effects of Viscoryl
Contact the doctor if side effects are troublesome or do not settle, or if breathing does not improve as expected. Some people report nervousness, headache, dizziness, tiredness or sleeplessness. Tell the doctor if any of these occur or worsen. Tell your doctor if any of these bother you or do not settle. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Tell the doctor before use about heart problems, especially coronary insufficiency, high blood pressure or irregular heartbeat, and about convulsive disorders, an overactive thyroid or diabetes. It is not known whether Levosalbutamol is excreted in human milk, so caution is needed in nursing women. Always ask your doctor or pharmacist if you have any questions about using this medicine. Keep out of reach of children.
Frequently asked questions
What does Viscoryl treat?
Viscoryl 1 mg/5 ml syrup is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease. Bronchospasm is a narrowing of the airways that makes breathing difficult.
How is Viscoryl used?
The exact number of inhalations, how often to use it and for how long are decided by your doctor. Measure the liquid with the cap or spoon that comes with the pack.
Can Viscoryl cause side effects?
Contact the doctor if side effects are troublesome or do not settle, or if breathing does not improve as expected. Some people report nervousness, headache, dizziness, tiredness or sleeplessness.
Levosalbutamol Nebuliser Solution or Inhaler is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.
Pharmacology
Levosalbutamol Nebuliser Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of Levosalbutamol, the (R)-enantiomer of the drug substance racemic salbutamol. Levosalbutamol Hydrochloride is a relatively selective β2 adrenergic receptor agonist.
Activation of β2 adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase and to an increase in the intracellular concentration of cyclic AMP. This increase in cAMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Levosalbutamol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles. Levosalbutamol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor.
Dosage & Administration
Nebuliser Solution: This Nebuliser Solutions supplied in unit-dose ampoules and requires no dilution before administration by nebulization.
Children (6 months-11 years): The recommended dosage is 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day.
Adults and Adolescents above 12 years old: The recommended starting dosage is 0.63 mg administered three to four times a day, every 6 to 8 hours, by nebulization.
Patients 12 years of age and older: With more severe asthma or patients who do not respond adequately: 0.63 mg of Levosalbutamol Nebuliser Solution may benefit from a dosage of 1.25 mg three times a day.
Inhaler: You should take your Levosalbutamol Inhaler as needed for an asthma attack at any time of day, with or without food, by taking 1-2 puffs up to 4 times daily and no more than 8 puffs in 24 hours. If you are using your Levosalbutamol Inhaler more than 3-4 times a week this may indicate that your asthma is not well controlled and you may need to review your medication. You can also use your Levosalbutamol Inhaler to prevent allergy or exercise induced asthma by taking 2 puffs 15 minutes before exercise or exposure to a known allergen.
Interaction
Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with Levosalbutamol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.
Beta-blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists such as Levosalbutamol Nebuliser Solution or Inhaler, but may also produce severe bronchospasm in asthmatic patients. However, under certain circumstances, e.g. prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardio selective beta-blockers could be considered with caution.
Diuretics: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics can be acutely worsened by beta-agonists when the recommended dose of the beta-agonist is exceeded.
Digoxin: It is necessary to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and Levosalbutamol Nebuliser Solution or Inhaler.
Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Levosalbutamol Nebuliser Solution or Inhaler should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents.
Side Effects
Potentially serious hypokalaemia may result from beta 2 - agonist therapy. This effect may be potentiated by hypoxia. Other side effects such as palpitation, fine tremors of the skeletal muscle (particularly the hand) and muscle cramps may occur. In few cases nervousness, headache, dizziness, fatigue and sleeplessness have also been reported.
Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies of Levosalbutamol Nebuliser Solution in pregnant women. Levosalbutamol Solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when Levosalbutamol Nebuliser Solution is administered to a nursing woman.
Precautions & Warnings
Levosalbutamol Hydrochloride, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Levosalbutamol Nebuliser Solution or Inhaler must not be injected.
Overdose Effects
The expected symptoms with over dosage are those of excessive beta-adrenergic receptor stimulation and/or occurrence or exaggeration of any of the symptoms listed under side effects. Treatment consists of discontinuation of Levosalbutamol Nebuliser Solution or Inhaler together with appropriate symptomatic therapy. The judicious use of a cardioselective beta-receptor blocker may be considered.
Storage Conditions
Store below 25°C. Protect from light. Do not refrigerate.
Alternative brands of Levosalbutamol
Other brands with the same generic name, cheapest first.